Bogdan A. Stoica

Iasi, IS, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Natural products modulate social behavior and gut microbiota in a valproic acid-induced zebrafish model of autism spectrum disorder.

Natural products modulate social behavior and gut microbiota in a valproic acid-induced zebrafish model of autism spectrum disorder.

Journal: Biomolecules & biomedicine

Published: April 20, 2026

The NLRP3 Inflammasome in Neuropsychiatric Disorders: Molecular Mechanisms and Emerging Therapeutic Strategies.

The NLRP3 Inflammasome in Neuropsychiatric Disorders: Molecular Mechanisms and Emerging Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: February 02, 2026

Integrated visualization and genetic profiling of latent fingerprints via UVITEX OB and adapted fluorescence microscopy.

Integrated visualization and genetic profiling of latent fingerprints via UVITEX OB and adapted fluorescence microscopy.

Journal: Forensic science international

Published: May 03, 2025

Behavioral and Biochemical Insights into the Therapeutic Potential of Mitocurcumin in a Zebrafish-Pentylenetetrazole (PTZ) Epilepsy Model.

Behavioral and Biochemical Insights into the Therapeutic Potential of Mitocurcumin in a Zebrafish-Pentylenetetrazole (PTZ) Epilepsy Model.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 22, 2025

Obesity-Induced PVAT Dysfunction and Atherosclerosis Development: The Role of GHSR-1a in Increased Macrophage Infiltration and Adipocytokine Secretion.

Obesity-Induced PVAT Dysfunction and Atherosclerosis Development: The Role of GHSR-1a in Increased Macrophage Infiltration and Adipocytokine Secretion.

Journal: Journal of cardiovascular development and disease

Published: November 28, 2024

Anti-Epileptic Activity of Mitocurcumin in a Zebrafish-Pentylenetetrazole (PTZ) Epilepsy Model.

Anti-Epileptic Activity of Mitocurcumin in a Zebrafish-Pentylenetetrazole (PTZ) Epilepsy Model.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 08, 2024

Montelukast Influence on Lung in Experimental Diabetes.

Montelukast Influence on Lung in Experimental Diabetes.

Journal: Medicina (Kaunas, Lithuania)

Published: March 05, 2024

Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic.

Factors Associated with Increased Risk of Urosepsis during Pregnancy and Treatment Outcomes, in a Urology Clinic.

Journal: Medicina (Kaunas, Lithuania)

Published: October 18, 2023

Montelukast influence on kidney in experimental induced diabetes mellitus.

Montelukast influence on kidney in experimental induced diabetes mellitus.

Journal: Pakistan journal of pharmaceutical sciences

Published: August 02, 2023

Overcoming Drug Resistance in a Clinical C. albicans Strain Using Photoactivated Curcumin as an Adjuvant.

Overcoming Drug Resistance in a Clinical C. albicans Strain Using Photoactivated Curcumin as an Adjuvant.

Journal: Antibiotics (Basel, Switzerland)

Published: July 09, 2023

Mitochondria-Targeted Curcumin: A Potent Antibacterial Agent against Methicillin-Resistant Staphylococcus aureus with a Possible Intracellular ROS Accumulation as the Mechanism of Action.

Mitochondria-Targeted Curcumin: A Potent Antibacterial Agent against Methicillin-Resistant Staphylococcus aureus with a Possible Intracellular ROS Accumulation as the Mechanism of Action.

Journal: Antibiotics (Basel, Switzerland)

Published: January 19, 2023

The Vital Role of Thanatochemistry in the Postmortem Diagnostic of Diabetic Ketoacidosis-Case Report.

The Vital Role of Thanatochemistry in the Postmortem Diagnostic of Diabetic Ketoacidosis-Case Report.

Journal: Diagnostics (Basel, Switzerland)

Published: May 03, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026